Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
2(29%)
Results Posted
50%(1 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
5
71%
Ph phase_2
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(2)
Terminated(3)

Detailed Status

Terminated2
Completed2
Recruiting1
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (28.6%)
N/A5 (71.4%)

Trials by Status

recruiting114%
terminated229%
completed229%
active_not_recruiting114%
withdrawn114%

Recent Activity

2 active trials
Showing 5 of 7
active_not_recruitingnot_applicable

Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo

NCT07532330
terminatedphase_2

UVB Phototherapy Treatment of Oral Chronic GVHD

NCT00374257
terminatednot_applicable

BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort

NCT04818138
completedphase_2

A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects

NCT03715829
withdrawnnot_applicable

Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)

NCT01818154
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07532330Not Applicable

Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo

Active Not Recruiting
NCT00374257Phase 2

UVB Phototherapy Treatment of Oral Chronic GVHD

Terminated
NCT04818138Not Applicable

BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort

Terminated
NCT03715829Phase 2

A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects

Completed
NCT01818154Not Applicable

Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)

Withdrawn
NCT03392337Not Applicable

An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients

Recruiting
NCT00407342Not Applicable

Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis.

Completed

All 7 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
7